Research to Watch
Project: Applied Statistical Genetics Group
Wellcome Trust Sanger Institute
Finding ways to analyze large amounts of genetic data and extract information related to diseases that involve multiple genes.
Project: Cancer Biology and Genetics Program
Testing a microfluidic chip that will measure differences in how genes are expressed in tumors.
Project: Coriell Personalized Medicine Collaborative
Coriell Institute for Medical Research
Enrolling 100,000 participants in a research study to measure how genetic information can improve health.
Project: Diagnostic Investigation of Sudden Cardiac Event Risk
Developing a genetic test that will identify patients at risk of sudden cardiac death who should receive an implantable defibrillator.
Catholic University of Leuven and others
An EU-funded consortium seeking to standardize genetic testing and establish guidelines for doctors and patients.
Project: Global Alliance for Pharmacogenomics
National Institutes of Health, RIKEN Yokohama Institute
An American-Japanese scientific alliance studying pharmacogenomics across a broad array of medical conditions, including depression, AIDS, and asthma.
Project: Pharmacogenomics Knowledge Base
Stanford University Medical Center and others
An international consortium building a database detailing the influence of genetic variations on drug reactions.
Project: Plavix, Effient Comparative Effectiveness Study
Investigating whether using genetic tests to determine a patient’s sensitivity to certain drugs is more cost-effective than choosing drugs that are less affected by genetic variations.
Project: The 1000 Genomes Project
Wellcome Trust Sanger Institute, Beijing Genomics Institute Shenzen, National Human Genome Research Institute
Sequencing the genomes of about 1,200 people around the world to create a database of biomedically relevant genetic variation.
Project: The Cancer Genome Atlas
National Cancer Institute, National Human Genome Research Institute
Sequencing thousands of samples from over 20 types of tumors to understand the genetic changes that underlie these cancers.
Geoffrey Hinton tells us why he’s now scared of the tech he helped build
“I have suddenly switched my views on whether these things are going to be more intelligent than us.”
Meet the people who use Notion to plan their whole lives
The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.
Learning to code isn’t enough
Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.
Deep learning pioneer Geoffrey Hinton has quit Google
Hinton will be speaking at EmTech Digital on Wednesday.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.